Log in to save to my catalogue

Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a H...

Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a H...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2478035512

Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform

About this item

Full title

Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform

Publisher

England: Oxford University Press

Journal title

Clinical chemistry (Baltimore, Md.), 2021-03, Vol.67 (3), p.554-563

Language

English

Formats

Publication information

Publisher

England: Oxford University Press

More information

Scope and Contents

Contents

Abstract
Background
With the advent of precision oncology, liquid biopsies are quickly gaining acceptance in the clinical setting. However, in some cases, the amount of DNA isolated is insufficient for Next-Generation Sequencing (NGS) analysis. The nCounter platform could be an alternative, but it has never been explored for detection of clin...

Alternative Titles

Full title

Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2478035512

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2478035512

Other Identifiers

ISSN

0009-9147

E-ISSN

1530-8561

DOI

10.1093/clinchem/hvaa248

How to access this item